318 related articles for article (PubMed ID: 10340366)
1. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
[TBL] [Abstract][Full Text] [Related]
2. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
[TBL] [Abstract][Full Text] [Related]
3. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1.
Huguenel ED; Cohn D; Dockum DP; Greve JM; Fournel MA; Hammond L; Irwin R; Mahoney J; McClelland A; Muchmore E; Ohlin AC; Scuderi P
Am J Respir Crit Care Med; 1997 Apr; 155(4):1206-10. PubMed ID: 9105055
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.
Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB
Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205
[TBL] [Abstract][Full Text] [Related]
5. Modification of experimental rhinovirus colds by receptor blockade.
Hayden FG; Gwaltney JM; Colonno RJ
Antiviral Res; 1988 Jul; 9(4):233-47. PubMed ID: 2849376
[TBL] [Abstract][Full Text] [Related]
6. Decreased rhinovirus shedding after intranasal oxymetazoline application in adults with induced colds compared with intranasal saline.
Winther B; Buchert D; Turner RB; Hendley JO; Tschaikin M
Am J Rhinol Allergy; 2010; 24(5):374-7. PubMed ID: 21244738
[TBL] [Abstract][Full Text] [Related]
7. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial.
Abisheganaden JA; Avila PC; Kishiyama JL; Liu J; Yagi S; Schnurr D; Boushey HA
Am J Med; 2000 Apr; 108(6):453-9. PubMed ID: 10781777
[TBL] [Abstract][Full Text] [Related]
8. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG
Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235
[TBL] [Abstract][Full Text] [Related]
9. Amplified rhinovirus colds in atopic subjects.
Bardin PG; Fraenkel DJ; Sanderson G; Dorward M; Lau LC; Johnston SL; Holgate ST
Clin Exp Allergy; 1994 May; 24(5):457-64. PubMed ID: 8087657
[TBL] [Abstract][Full Text] [Related]
10. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
Hayden FG; Gwaltney JM
J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds.
Sperber SJ; Sorrentino JV; Riker DK; Hayden FG
Bull N Y Acad Med; 1989 Jan; 65(1):145-60. PubMed ID: 2557947
[TBL] [Abstract][Full Text] [Related]
12. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds.
Proud D; Gwaltney JM; Hendley JO; Dinarello CA; Gillis S; Schleimer RP
J Infect Dis; 1994 May; 169(5):1007-13. PubMed ID: 8169385
[TBL] [Abstract][Full Text] [Related]
14. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
Hayden FG; Gwaltney JM
J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
[TBL] [Abstract][Full Text] [Related]
15. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
Avila PC; Abisheganaden JA; Wong H; Liu J; Yagi S; Schnurr D; Kishiyama JL; Boushey HA
J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
[TBL] [Abstract][Full Text] [Related]
16. Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection.
Winther B; Arruda E; Witek TJ; Marlin SD; Tsianco MM; Innes DJ; Hayden FG
Arch Otolaryngol Head Neck Surg; 2002 Feb; 128(2):131-6. PubMed ID: 11843719
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.
Farr BM; Gwaltney JM; Hendley JO; Hayden FG; Naclerio RM; McBride T; Doyle WJ; Sorrentino JV; Riker DK; Proud D
J Infect Dis; 1990 Nov; 162(5):1173-7. PubMed ID: 2172395
[TBL] [Abstract][Full Text] [Related]
18. PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials.
Malcolm BA; Aerts CA; Dubois KJ; Geurts FJ; Marien K; Rusch S; Van Dijck AH; Verloes R; Vingerhoets J
Antiviral Res; 2018 May; 153():70-77. PubMed ID: 29567461
[TBL] [Abstract][Full Text] [Related]
19. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.
Turner RB; Woodfolk JA; Borish L; Steinke JW; Patrie JT; Muehling LM; Lahtinen S; Lehtinen MJ
Benef Microbes; 2017 Apr; 8(2):207-215. PubMed ID: 28343401
[TBL] [Abstract][Full Text] [Related]
20. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.
Farr BM; Conner EM; Betts RF; Oleske J; Minnefor A; Gwaltney JM
Antimicrob Agents Chemother; 1987 Aug; 31(8):1183-7. PubMed ID: 2820298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
